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INTRODUCTION:
1. ENZYME:
Enzymes  are  biomolecules  or  proteins  materials  that  catalyze  chemical  reactions.  In
enzymatic reactions, the molecules at the beginning of the process are called substrates, and the
enzyme converts them into different molecules, called the products. Almost all processes in a
biological cell need enzymes to occur at significant rates. Since enzymes are selective for their
substrates and speed up only a few reactions from among many possibilities, the set of enzymes
made in a cell determines which metabolic pathways occur in that cell. [1]
 In 1878, German physiologist Wilhelm Kuhner first used the term enzyme, which comes
from Greek word “in leaven”, to describe this process. The word enzyme was used later to refer
to nonliving substances such as pepsin.
 Like all catalysts, enzymes work by lowering the activation energy for a reaction, thus
dramatically increasing the rates of the reaction.  Most enzyme reaction rates are millions of
times faster than those of comparable un-catalyzed reaction. As with all catalysts, enzymes are
not consumed by the reactions they catalyze. [2]
Advantages of Enzymes: [2]
Enzymes are a sustainable alternative to the use of dangerous chemicals in industry 
because of their following advantages:
They are specific, will generate only one product and no other.
Generally operate in aqueous solutions which are cheaper and safer than organic solvent.
Reduce energy consumption by eliminating the need to maintain extreme environments.
Enzymes are both economically and environmentally feasible.
Applications of Enzymes [2]
Uses of enzymes can be classified as:-
(1)Medicinal and Clinical Use:-
Enzymes can be used for Aiding Digestion. Example: Amylases, Proteases and Lipase.
They can also be used as Deworming agents. Example: Papain.
Enzymes act as anti-clotting agents like Fibrinolytic and Thrombolytic. Examples: Urokinase 
and Streptokinase.
Enzymes can be used as surface disinfectants. Example: Trypsin.
They can also be used in the diagnosis purpose. Example: Glucose oxidase along with 
peroxidase to detect the level of glucose (colorimetric estimation).
       Liver disease                            :  SGPT, SGOT
       Heart attacks                            : SGOT
      Myocardial Infarction (MI)      : Creatine phosphokinase.
(2)Industrial purpose:-
 Enzymes can be used in the textile industry. Example: Amylase as softening agent for 
starched clothes.
 They can also be used for Leather purpose. Example: Proteolytic purpose.
 Enzymes have the importance in the paper manufacturing. Examples: Endoxylanases for 
bleaching of Wood pulp.
 They can be used in the manufacturing of organic compounds. Example: Bacterial 
enzymes for the manufacturing of acetone, butanol, lactic acid etc.
(3)Enzymes used in food industry:-
Enzymes can be used in the meat packing industry. Example: Papain which is proteolytic
in action, therefore hydrolyses peptide bonds thus for tenderizing meat and beef.
Enzymes have their role in Manufacturing of cheese. Example: Rennin (chymosin) found
in stomach, converts milk protein casein to curd like calcium paracaseinate.
(4)Beverage industry:-
Papain is used to stabilize chill bear. Yeast enzymes are also used in beverage industry.
(5)Ice Cream:-
Lactose is used to prevent the formation of lactose crystals in ice-cream preparations.
(6)Research:-
Several enzymes are used for detection of biochemical reactions.
2. L-asparaginase:  [4-16]
L-asparaginase (L-asparagine amino hydrolase EC 9.5.1.1) is a potent antitumor enzyme
that catalyzes the hydrolysis of L-asparagine to L-aspartic acid and ammonium ion.
The  chemical  reaction  of  l-asparagine  to  l-aspartic  acid  and  ammonia  by
L-asparaginase.
             L-Asparagine + H2O Asparaginase> L-Aspartate + NH3
This  enzyme  has  been  widely  exploited  in  the  treatment  of  certain  kinds  of  cancer
especially acute lymphoblastic Leukemia since the time it was obtained from Escherichia coli
and its antineoplastic activity demonstrated in guinea pig serum .[4-6]
Asparaginases  are widely distributed in  nature from bacteria  to  mammals  and play a
central role in the amino acid metabolism and utilization. In human body, L-aspartate plays an
important  role  as  a  precursor  of  ornithine in  the urea  cycle  and in  transamination reactions
forming oxalo acetate in the gluconeogenic pathway leading to glucose formation. [7]
L-asparaginase is a unique cancer chemotherapeutic agent [8]. It has been demonstrated
that this enzyme is responsible for anti lymphoma activity in guinea pig serum. [9]
L-asparaginase is the first enzyme with anti leukemic activity to be intensively studied in
human  Beings [10].  Cancer  cells  differentiate  themselves  from  normal  cells  in  diminished
expression of L-asparagine [11]. So, cancer cells are unable to produce L-asparagine and depend
on external L-asparagine from the circulating blood plasma [12].  Since 1922, L-asparaginase has
been  considered  as  a  therapeutic  agent  against  malignant  tumors [13-14].  A  wide  range  of
microorganisms such as  filamentous fungi,  yeasts,  and bacteria  have proved to be beneficial
sources of this enzyme. [15-16]
STRUCTURE: 
                         
                                                L-asparaginase structure      
                                                          Figure: 1
SOURCE: [18]
L-Asparaginase is produced by a large number of microorganisms that include  E. coli
(Derst et al., 1994; Mercado & Arenas, 1999), Erwinia cartovora
(Maladkar  et  al.,  1993;  Aghaiypour  et  al.,  2001),  Enterobacter  aerogenes (Mukherjee  et  al.,
2000),  Corynebacterium  glutamicum (Juan  et  al.,  1990),  Candida  utilis (Kil  et  al.1995),
Staphylococcus aureus (Muley et al., 1998), Thermus thermophilus (Prista & Kyridio, 2001), and
Pisum sativum (Siechiechowcicz & Ireland, 1989). [18]
MICRO-ORGANISM:
The Bacterial strain of Pseudomonas aeruginosa was collected from MTCC.
The stock culture was maintained on tryptic soy agar slants that contained tryptic casein 
Bios D (1.5%), Soy peptone (0.5%), NaCl (0.5%), and agar Bios U (1.5%). The culture was 
incubated at 37oC for 18 h and stored at 4oC.
MEDIA: [19]
Soybean Casein Digest Medium (Tryptone Soya Broth) :
Soybean Casein Digest Medium is a general purpose medium used for cultivation of a
wide variety of  microorganisms and Recommended for sterility testing of  moulds and lower
bacteria.
Composition:
Ingredients Gms / Litre
Pancreatic digest of casein 17.000 Gms
Papaic digest of soyabean meal 3.000 Gms
Sodium chloride 5.000 Gms
Dextrose 2.500 Gms
Dibasic potassium phosphate 2.500 Gms
Final pH (at 25°C) 7.3±0.2 Gms
FERMENTATION: [20]
Types of fermentation techniques
Solid-State Fermentation (SSF)
SSF utilizes solid substrates, like bran, bagasse, and paper pulp. The main advantage of
using these substrates is that nutrient-rich waste materials can be easily recycled as substrates. In
this fermentation technique,  the substrates are utilized very slowly and steadily,  so the same
substrate can be used for long fermentation periods. Hence, this technique supports controlled
release  of  nutrients.  SSF  is  best  suited  for  fermentation  techniques  involving  fungi  and
microorganisms that require less moisture content. However, it cannot be used in fermentation
processes involving organisms that require high aw (water activity), such as bacteria.(Babu and
Satyanarayana, 1996).
Submerged Fermentation (SmF)/Liquid Fermentation (LF)
SmF utilizes free flowing liquid substrates, such as molasses and broths. The bioactive
compounds are secreted into the fermentation broth. The substrates are utilized quite rapidly;
hence need to be constantly replaced/supplemented with nutrients. This fermentation technique is
best suited for microorganisms such as bacteria that require high moisture content. An additional
advantage of this technique is that purification of products is easier. SmF is primarily used in the
extraction of secondary metabolites that need to be used in liquid form. [20]
PURIFICATION:
Purification of L-asparaginase: [43-44] 
The purification was carried out at 4ºC on the crude extract, according to the modified
method of Distasio et al. (1976).
Ammonium sulfate fractionation
Finely powdered ammonium sulfate was added to a 80% saturation. The mixture was left 
for 12h at 4oC, followed by centrifugation at 8,000 rpm for 20 min at 4oC.
The  precipitate  was  dissolved  in  a  0.01  M  phosphate  buffer  pH  8.5  and  dialyzed
overnight against the same buffer at 4oC.
The enzyme was assayed by the direct nesslerization method according to the method of
Sinha  et  al.,  (1991).  One L-asparaginase unit  (IU) is  defined as  the enzyme amount,  which
liberates 1 µmol of the ammonia/min under optimal assay conditions. The protein concentration
was determined by the modified Lowry’s method (Kim et al., 2002).
Disc-PAGE: [18]
A slab gel electrophoresis was carried out using a 15% polyacrylamide gel (pH 7.8) with a 5%
top gel (pH 6.2). After electrophoresis in a Tris-glycine buffer (pH 8.3) at 200 V for 7 h at 70oC,
the proteins in the gel were stained with Coomassive brilliant blue R-250 and destained (El-
Gamal et al., 2001). [18]
3. CURRENT STATUS ON THE PRODUCTION OF L-ASPARAGINASE:
The present research work focus on mutation, immobilization of the whole-cell  Pseudomonas
aeruginosa and optimize the fermentation medium (Soybean Casein Digest Medium) to produce
cell free enzyme with high quality and quantity and low cost. 
4. CANCER: [21] 
Cancer is a potentially fatal disease caused mainly by environmental factors that mutate
genes encoding critical cell-regulatory proteins (Malcolm R Alison, 2001). The resultant aberrant
cell  behaviour  leads  to expansive masses of  abnormal cells  that  destroy surrounding normal
tissue and can spread to vital organs resulting in disseminated disease; commonly a harbinger of
imminent  patient  death,  the  cancer-causing agents  (carcinogens)  can  be present  in  food  and
water, in the air, and in chemicals and sunlight that people are exposed to. [21] 
HISTORY OF CANCER: [20]                                         
Human beings and other animals have had cancer throughout recorded history. Cancer
was discovered in Egypt and dates back to about 3000 BC. Although the term cancer was not
used. The origin of the word cancer is credited to the Greek physician Hippocrates (460-370) He
used the terms carcinos and carcinoma (which mean crab) to describe non-ulcer forming and
ulcer  forming tumors.  Later  the  Roman physician Celsius  (28-50AD) translated  the  term to
cancer. [20]
CAUSES OF CANCER: [21]
During  the  1970s,  scientists  discovered  two  particularly  important  families  of  genes
related to cancer, oncogenes and tumor suppressor genes.
Oncogenes:  These genes cause cells to grow out of control and become cancer cells. They are
formed by changes  or  mutations  of certain normal genes of the cell  called  proto-oncogenes.
Proto-oncogenes are the genes that normally control how often a cell divides and the degree to
which it differentiates (or specializes in a specific function in the body).
Tumor suppressor genes:  These are normal genes that slow down cell division, repair DNA
errors, and tell cells  when to die (a process known as  apoptosis  or  programmed cell death).
When tumor suppressor genes don’t work properly, cells can grow out of control, which can lead
to cancer. [21]
CAUSES:
Different types of cancer have different causes and are likely to depend on many factors.
Some cancers are more common than others,  and chances for survival  vary among different
types.  Most  cancers  do  not  have  known  causes  from  a  chemical,  environmental,  genetic,
immunologic, or viral origin. Cancers also can arise spontaneously from causes that are thus far
unexplained.
The causes of cancer are very complex, involving both the cell and factors in the 
environment. Much progress has been made in identifying possible causes of cancer, including:
1-Chemicals and other substances: Being exposed to substances such as certain chemicals, 
metals, or pesticides can increase the risk of cancer. Any chemical that is known to cause cancer 
is called a carcinogen.
Example:
                 Asbestos, nickel, cadmium, uranium, radon, vinyl chloride, benzidene, and benzene
2-Tobacco: The  most  common carcinogens  in  our  society  are  those  present  in  cigarette
smoke. Tobacco smoke is known to contain at  least 60 carcinogens and 6 developmental
toxicants. In addition to being responsible for 80 to 90 percent of lung cancers,  cigarette
smoking is also associated with cancers of the mouth, pharynx, larynx, esophagus, pancreas,
kidney, and bladder. Avoiding tobacco products is one way to decrease a person’s risk of
cancer. 
3-Ionizing  radiation:  Certain  types  of  radiation,  such  as  x-rays,  rays  from  radioactive
substances, and ultraviolet rays from exposure to the sun, can produce damage to the DNA of
cells, which might lead to cancer.
4- Heredity: Certain types of cancer occur more frequently in some families than in others, 
indicating some inherited predisposition to the development of cancer. Even in these cases, 
however, environment plays a part in the development of cancer. [22]
TYPES OF CANCER: [22]                                 
Tumors are found in all kinds of tissue, and can be benign or malignant.
  Benign tumors are not cancer: They usually can be removed and, in most cases, they do
not come back. Most important, cells from benign tumors do not spread to other parts of the
body. Cells from benign tumors stay together and often they are surrounded by a containing
membrane. Benign tumors are not usually a threat to life.            
 Examples of Benign Tumors 
 Papilloma A projecting mass on the skin (for example, a wart)
 Adenoma A tumor that grows in and around the glands
 Lipoma A tumor in fatty tissue           
 Malignant tumors are cancer: Cancer cells can invade and damage tissues and organs
near the tumor. Cancer cells also can break away from a malignant tumor and enter the lymphatic
system or the bloodstream, which is  how cancer  can spread to other  parts  of  the body.  The
characteristic  feature  of  cancer  is  the  cell’s  ability  to  grow  rapidly,  uncontrollably,  and
independently from the tissue where it started. The spread of cancer to other sites or organs in the
body through the blood stream or lymphatic system is called metastasis.
Malignant tumors generally can be classified in two categories. 
Carcinomas: These cancers originate in the epithelium. The epithelium is the lining cells
of an organ. Carcinomas are the most common type of cancer. Common sites of carcinomas are
the skin, mouth, lung, breast, stomach, colon and uterus. 
Sarcomas: Sarcomas are cancers of connective and supportive tissue (soft tissues) of all
kinds. Sarcomas can be found anywhere in the body, and they often form secondary growths in
the lungs. [22]
Common Types of Cancer: [23]
Skin cancer is the most commonly diagnosed cancer among men and women. Over one
million cases are diagnosed each year, with more young people having skin cancer than ever
before. The most common types of cancer in the United States based on frequency of diagnosis
are:
Bladder cancer
Breast cancer 
Colon cancer
Endometrial cancer
Kidney cancer (renal cell)
Leukemia 
Lung cancer 
Melanoma 
Non-Hodgkin lymphoma 
Pancreatic cancer 
Prostate cancer 
Thyroid cancer 
Types of Cancer Classified by Body System: [23]
Cancer has the potential to affect every organ in the body. The cells within malignant
tumors have the ability to invade neighboring tissues and organs, thus spreading the disease. It is
also possible for cancerous cells to break free from the tumor and enter the bloodstream, in turn
spreading the disease to other organs. This process of spreading is called metastasis.
When cancer has metastasized and has affected other areas of the body, the disease is still
referred to the organ of origination. For instance, if cervical cancer spreads to the lungs, it is still
called cervical cancer, not lung cancer.
Blood Cancer: The cells in the bone marrow that give rise to red blood cells, white blood cells,
and platelets can sometimes become cancerous. These cancers are leukemia or lymphoma. 
Bone Cancer: Bone cancer is a relatively rare type of cancer that can affect both children and
adults, but primarily affects children and teens. There are several types of bone cancer.
Brain Cancer: Brain tumors  can be malignant  (cancerous)  or  benign (non-cancerous).  They
affect  both children and adults.  Malignant brain tumors  don't  often spread beyond the brain.
However, other types of cancer have the ability to spread to the brain. 
Breast Cancer: Breast cancer is a type of cancer that affects women. More than 200,000 women
are diagnosed with breast cancer in the United States each year.
Digestive/Gastrointestinal Cancers This is a broad category of cancer that affects everything
from the esophagus to the anus. Each type is specific and has its own symptoms, causes, and
treatments. 
Endocrine Cancers: The endocrine system is an instrumental part of the body that is responsible
for glandular and hormonal activity. Thyroid cancer is the most common of the endocrine cancer
types and generally. 
Eye Cancer: Like other organs in the human body, the eyes are vulnerable to cancer as well. Eye
cancer  can  affect  both  children  and  adults.
Genitourinary Cancers: These types of cancer affect the male genitalia and urinary tract. 
Gynecologic Cancers: These groups of cancer types affect the organs of the female reproductive
system.  Specialized oncologists  called gynecologic  oncologists are recommended  for  treating
gynecologic cancer. 
Head and Neck Cancer: Most head and neck cancers affect moist mucosal surfaces of the head
and neck, like the mouth, throat, and nose. Causes of head and neck cancer vary, but cigarette
smoking plays a role. Current research suggests a strong HPV link in the development of some
head  and  neck  cancer. 
Respiratory  Cancers: Cigarette  smoking  is  the  primary  cause  for  cancer  affecting  the
respiratory system. Exposure to asbestos is also a factor. 
Skin Cancers:
Non-melanoma skin cancer is the most common type of cancer among men and women.
Exposure to the UV rays of the sun is the primary cause for non-melanoma skin cancer and also
melanoma.
TREATMENTS OF CANCER: [24]
Cancer treatment is  usually a combination of a number of different modalities.  If  the
tumour is amenable to surgery, then surgery is the single most effective tool in the anticancer
armamentarium.  Targeted  radiotherapy  is  another  option,  as  are  combinations  of  anticancer
drugs.  Most  conventional  anticancer  drugs  have  been  designed  with  deoxyribonucleic  acid
(DNA) synthesis as their Target. Therein lies the problem, in that tumour cells are not the only
proliferating cells in the body such as bone marrow cells that generate red blood cells and cells to
fight  infection,  and  epidermal  cells  including  those  that  generate  hair  are  all  highly
proliferativeThus, patients with cancer receiving chemotherapy commonly suffer unwanted (hair
loss)  and  sometimes  potentially  life-threatening  (anaemia  and  proneness  to  infections)  side
effects that limit treatment. The new generations of drugs have targets removed from the direct
synthesis of DNA; they affect the signals that promote or regulate the cell cycle, growth factors
and  their  receptors,  signal  transduction  pathways  and  pathways  affecting  DNA repair  and
apoptosis [23].
Anticancer drugs (1980) [25]
Table: 1
Alkylating agents Nitrogen mustards: cyclophosphamide, melphalan,
                                   Chloroambucil
Ethylsulfonates       :  busulfan
Triazenes                 : dacarbazine
Antibiotics               : mitomycin-C
Antimetabolites Folic acid analogs    : methotrexate
Pyrimidine analogs  : 5-fluorouracil, cytarabine, 
                                    5-azacytidine       
Purine analogs          : 6-mercaptopurine,      
                                    6-thioguanine                                     
Substituted ureas      : hydroxyurea
Natural products Antimitotics Vinca alkaloids: vincristine, vinblastine,          
Podophyllotoxins      : etoposide, tenoposide
Antibiotics                 : doxorubicin, daunorubicin,        
bleomycin, Actinomycin-D, mithramycin
Enzymes L-Asparaginase
Hormones and antagonists Adrenocorticosteroids: prednisone
Progestins: hydroxyprogesterone caproate, 
medroxyprogesterone
Acetate, megestrol acetate
Estrogens: diethylstilboestrol, ethyniloestradiol
Miscellaneous agents: Cisplatin, procarbazine, mitotan 1-asparaginase
Anticancer drugs (1999) [25]
Table: 2 
Alkylating agents Nitrogen mustards  estracyte
Oxazaphosphorines            ifosfamide
Hexitols                              mitobronitol
Nitrosoureas                        photemustine
Triazenes                temozolomide,  
altretamine
Aziridines                           mitomycin-C
Platinum complexes Carboplatin, oxalyplatin
Topoisomerase inhibitors Camptothecin topotecan, irinotecan
Podophyllins etoposide, tenoposide
Antimetabolites Folate analogs            trimetrexate
Purine analogs            fludarabine
Adenosine analogs     cladribine, pentostatine
Pyrimidine analogs       floxouridine,                            
gemcitabine, capecitabine
Antimitotics(microtubule agents) Vincas vinorelbine
Taxanes paclitaxel, docetaxel
Antibiotics Glycopeptids pepleomycin
Anthracyclins epirubicin, idarubicin, esorubicin
Anthracenedions mitoxantron. Losoxantron
Hormonal agents SnRH analogs                octreotide, lanreotide
GnRH analogs                leuprolide, buserelin, goserelin, 
tryptorelin
Aromatase inhibitors        aminogluthetimide,    fadrozole, 
vorozole, anastrozole,
Letrozole, examestane, formestane
Antioestrogens           toremifene, raloxifene
Antiandrogens                 flutamide, casodex
Others     fluoxymesterone, diethylstilboestrol
New approaches in cancer therapy (2000) [25]
Table: 3
Class Mechanism Agent Investigational 
phase
Chemoprotective 
drugs 
Transformation of 
precancerous to normal 
cell
All-trans-retinoic acid, 
etretinate, fenretinide, 
sulindac, raloxifene
II-III
Differentiating agents Induction of cell 
differentiation
Phosphocholines, 
alkylglycerols, HMBA, 
DMSO, MAP
Preclinical + I
Revertants Drugs bypassing MDR 
type resistance
Verapamil, dipins, sporins
(e.g. staurosporin) various
cytostatics
I-II
Natural products various or not yet 
clarified
Plant extracts: (e.g. 
genistein, quercetin, 
chelidonin, marine 
products:
Dolastaatin, bryostatin, 
halichondrin)
Preclinical + I-II
Supportive drugs Cytoprotective agents
– Hemopoiesis
– Other organs
Antibiotics
Analgesics 
Antiemetics 
Bisphosphonates 
IL-3, erythropoietin, G-
CSF, thrombopoietin 
Mesna, amifostine, 
dexrazoxane 
III generation 
cephalosporins, 
macrolides, antivirals 
(acyclovir, gancyclovir),
Antimycotics (fluconazol)
Morphine derivatives, 
fentanyl
Ondansetron, tropisetron, 
granisetron, dolasetron
Chlodronate, etidronate, 
pamidronate, allendronate
II-III
II-III
III
III
III
III
Bioreductive agents Tumour oxigenation Tirapazamine I-II
enhancement
Antitelomerases Blocking telomerase Telomerase inhibitors Investigational
Angiogenesis inhibitors Induction of 
vascular discontinuity
Blocking endothelial 
locomotion
Inhibiting endothelial 
proliferation
Blocking endothelial 
sprouting
Metalloproteinase 
inhibitors, angostatic 
steroids
Fumagillin + analogs, 
platelet factor 4 protamine
Inhibitors of VEGF and 
FGF
Marinastat, batimastat
Thalidomid
Angiostatin
Endostatin 
Proline analogs, 
cyclosporine
Preclinical + I
Preclinical + I-II
I-II
II-III
II
I
Investigational
II-III
REVIEW OF LITERATURE:
ENZYME:
• Mirjafari et al [4] (2007) Biological sequestration of carbon dioxide (CO2) in geological
formations is one of the proposed methods to reduce the carbon dioxide released into the
atmosphere. In this method, an enzyme is used to enhance the hydration and subsequent
precipitation of CO2. In the present work, the effect of bovine carbonic anhydrase on the
hydration of CO2, and its precipitation in the form of calcium carbonate, was studied. The
enzyme enhanced the hydration reaction. The rate of hydration reaction increased with
both the enzyme concentration and temperature. The precipitation of calcium carbonate
was promoted in the presence of the enzyme. The concentration of the enzyme did not
affect  the  precipitation;  however,  temperature  impacted  the  precipitation  of  calcium
carbonate.  At  higher  temperatures,  less  calcium  carbonate  was  formed.  Also,  in  the
presence of the enzyme, calcium carbonate settled more quickly.  The enzyme activity
was  not  influenced  by the  pH of  the  reaction  mixture.  In  contrast,  the  formation  of
calcium  carbonate  was  affected  by  the  pH  of  the  solution.  A kinetic  analysis  was
performed for  the bovine carbonic anhydrase.  Based on the  experimental  results,  the
activation energy and catalytic rate constant are estimated as700.91 cal/mol and 0.65s-1,
respectively.
L-ASPARAGINASE:
• El-Bessoumy et al [18] (2004) The L-asparaginase (E. C. 3. 5. 1. 1) Enzyme was purified
to homogeneity from  Pseudomonas aeruginosa  50071 cells that were grown on solid-
state fermentation. Different purification steps (including ammonium sulfate fractionation
followed by separation on Sephadex G-100 gel filtration and CM-Sephadex C50) were
applied to the crude culture filtrate to obtain a pure enzyme preparation. The enzyme was
purified 106-fold and showed a final specific activity of 1900 IU/mg with a 43% yield.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
• of the purified enzyme revealed it was one peptide chain with  Mw of 160 kDa. A Line
weaver-Burk  analysis  showed a  Km  value  of  0.147  mM and  Vmax  of  35.7  IU.  The
enzyme showed maximum activity at  pH 9 when incubated at  37ºC for 30 min. The
amino acid composition of the purified enzyme was also determined.
CANCER:
• Malcolm R Alison [21] (2001)  Cancer  is  a  potentially fatal  disease  caused  mainly by
environmental factors that mutate genes encoding critical cell-regulatory proteins. The
resultant aberrant cell behaviour leads to expansive masses of abnormal cells that destroy
surrounding  normal  tissue  and  can  spread  to  vital  organs  resulting  in  disseminated
disease, commonly a harbinger of imminent patient death.
• American Society of Clinical Oncology [22](2009)The study of cancer, called oncology,
is the work of countless doctors and scientists around the world whose discoveries in
anatomy, physiology, chemistry, epidemiology, and other related fields made oncology
what it is today. Technological advances and the ever-increasing understanding of cancer
make this field one of the most rapidly evolving areas of modern medicine.
• www.atsdr.cdc.gov [23] Cancer is not a single disease. It  is a group of more than 200
different  diseases.  Cancer  can  be  generally  described  as  an  uncontrolled  growth  and
spread of abnormal cells  in the body.  Cells  are basic units  of  life.  All  organisms are
composed of one or more cells. Normally, cells divide to produce more cells only when
the body needs them. 
• Sometimes  cells  keep  dividing and  thus  creating more  cells  even  when they are  not
needed .When this happens, a mass of tissue forms. This mass of extra tissue is called a
tumor. Tumors are found in all kinds of tissue, and can be benign or malignant.
SCREENING:
• R.GULATI  et  al [27]  (1997)  A pH  and  dye-based  fast  procedure  for  screening  L-
asparaginase  producing  micro-organisms  is  reported.  The  procedure  is  suitable  for
bacterial and fungal screening. The results are obtained within 24and48 hours for bacteria
and  fungi,  respectively  .the  results  correlate  with  quantitative  estimations  in  culture
broths.
• Dharmaraj et  al  [28] (2011) L-asparaginase  is  an  anti-neoplastic  agent  used  in  the
chemotherapy of lymphoblastic leukaemia. The present work deals with production of
extra-cellular Lasparaginase from marine actinomycetes, using submerged fermentation.
Marine actinomycetes Streptomyces associated with marine sponge Callyspongia diffusa
was  isolated  using  specific  ISP  medium.  Sponge-associated  Streptomyces  was
characterized by conventional methods, and identified as  Streptomyces noursei  MTCC
10469. Production of Lasparaginase by submerged fermentation was carried out using
medium Tryptone Glucose Yeast extract (TGY) broth. The enzyme was purified to near
homogeneity by ammonium sulphate precipitation, dialysis, gel filtration on Sephadex G-
100 column, CM Sephadex C-50 and SDS-PAGE. The enzyme was purified at 98.23
folds, and showed a final specific activity of 78.88 IU/mg, with 2.14% yield. SDS-PAGE
of the purified enzyme revealed an apparent molecular weight of 102 kDa for it.  The
optimum pH, temperature and incubation time of L-asparaginase was found to be 8, 50ºC
and 35  min,  respectively.  The  study suggests  that  marine  actinomycetes,  particularly
Streptomyces, may be used as a potential source of L-asparaginase.
• Kamble et al [29] (2012) Due to the hazards of chemotherapeutic drugs and its painful
effects,  L-asparaginase  are  emerging  as  safer  source  of  anticancer  enzymes.  Genetic
studies and enzyme purification studies has always been simpler with regards to bacteria
hence  bacteria  are  also  preferred  source  for  L-asparaginase  production.  Study so  far
reports  some  of  the  bacterial  L-asparaginase  is  allergic  and  therefore  there  is  a
considerable  need  to  find  alternative  bacterial  L-asparaginase.  We  have  employed  a
media containing L-asparagine as principle carbon source for screening of l-asparaginase
producing bacteria. Twenty isolates were obtained after screening various soil samples. A
qualitative assay was performed in order to select the efficient  bacteria.  Out of these
isolates twelve efficient bacteria are further selected for physiological studies and carbon
sources utilization. Optimization of pH and temperature is also studied. We have also
performed  a  comparative  assay  of  these  isolates  for  Lasparaginase  production.  The
bacterial  genera belong to  Paenibacillus  species,  B. subtilis,  Aneurinibacillus species,
Staphylococcus species, S. saprophyticus, Brevibacillus species and Micrococcus species.
• Kamble et  al [30] (2012) the habitat  chosen for screening the bacteria were farm soil,
saline soil and water. The activity was detected on a medium containing 1% peptone,
0.6% beef extract, 0.33% KH3PO4, 0.1% L-asparagine and phenol red.   L-asparaginase
activity was detected on the basis of formation of red colour around the colony. Likewise
efficient L- asparaginase producing bacteria were screened. These were then studied for
routine  microbiological  and  biochemical  characterization.  The  microorganisms  we
characterized  belonged  to  the  genera  E.coli,  Serratia  spp.,  Pseudomonas  aeruginosa,
Bacillus  spp.,  Aeromonas  species  and  Proteus  spp.  L-asparaginase  from  halophilic
bacteria is expected to be non-allergic and hence halophilic bacteria from saline soil can
contribute to therapeutic value of this enzyme.
• Verma et al [31] (2012) Present scenario has focused that L- asparaginase has been found
to be best anti leukemic agent. It  has been characterized based on the assay principle
hydrolyzing L-asparagine  into  L-aspartic  acid  and  ammonia.  Withania somnifera (L.)
Dunal  (Ashwagandha);  Traditional  ayurvedic  medicinal  plant,  used  in  treatment  of
various diseases, found to have good source of enzyme L-asparaginase. In present study,
different cytotypes of  W. somnifera were compared for ploidy level and L-asparaginase
activity.  L-asparaginase was extracted from diploid and tetraploid  Withania somnifera
plants and tetraploid was found to have three times higher activity. Enzyme was purified
using  ammonium  sulphate  precipitation,  Ion  exchange  and  gel  permeation
chromatography. Purified L-asparaginase revealed molecular weight 75 kDa, Km value
1.5 mM and Vmax 526.31 µM/min. Purified enzyme has 61.22 % yield with 13.87 fold
increase in specific activity
• SUKUMARAN  et  al [32] (1979) the production of  L-asparaginase by two mutants  of
Serratia  marcescens  grown  on  14  different  media  was  studied.  The  enzyme content
increased from trace levels to 2·4 international units per ml when the organisms were
grown in glycerol-peptone yeast  extract  medium. Glucose was the best carbon source
under aerobic conditions. The enzyme content increased when L-asparagine was present
in the growth medium.
• Moharam et al [33] (2010) L-asparaginase is one of the known drugs in the treatment of
cancer, especially acute lymphoblastic leukemia. In recent years several bio-conjugation
protocols  have  been  developed  to  improve  the  pharmacokinetic  and  immunological
properties of anti-leukemic enzyme,             L-asparaginase. In this study, fifty two bacilli
species were newly isolated in our laboratory and screened for their ability to produce
extracellular and intracellular Lasparaginase enzyme.  Bacillus  sp R36 gave the highest
intracellular  enzyme  production.  Formation  physiology  of  the  enzyme  revealed  that
optimum culture  conditions  were  9:1  of  air::medium  ratio,  with  55  x  105  CFU/mL
inoculums size. The optimum incubation period was found to be 24 hours under shaking
growth  conditions.  The  initial  pH  value  5.6  was  favorable  for  the  highest  enzyme
production.  Addition  of  1%  lactose  or  1%  raffinose  resulted  in  a  doubled  enzyme
productivity  (yielded  204%  and  209%,  respectively).  The  enzyme  was  efficiently
immobilized by covalent binding with activated carbon. Immobilized                           L-
asparaginase  activity  was  33.0  U/g  carrier;  with  immobilization  yield  of  73.6%.
Characterization  of  the  enzyme  was  performed  on  native  and  immobilized  forms.
Optimum  pH  value  was  7.0  for  free  and  immobilized  forms.  Optimum  reaction
temperature  was  50  °C  for  native  enzyme,  while  it  was  60  °C for  the  immobilized
enzyme preparation. The immobilization process greatly enhanced the thermal stability of
the enzyme. Native L -asparaginase enzyme exhibited thermal stability up to 50 °C, while
immobilized form retained 100% of its activity up to 80 °C. Anti-tumor and antioxidant
activities were investigated. The enzyme inhibited the growth of two human cell lines
including hepatocellular carcinoma (Hep-G2) and colon carcinoma (HCT-116) with IC50
value of 112.19 µg/mL and 218.7 µg/mL, respectively.
MUTATION:
• AMENA et al [34](2012) in the present study, the strain  Streptomyces gulbargensis  was
subjected to mutagenesis by physical and chemical agents like UV rays, Ethyl methane
sulphonate and Ethidium Bromide in order to isolate strains capable of producing higher
yields of L-asparaginase than the prototype. A total of thirty two mutants were obtained,
however among all the mutants, S. Gulbargensis mu24 was found to be the most potent.
The maximum L-asparaginase activities recorded with  S. gulbargensis  and its  mutant
were 30 IU and 44.7 IU respectively at  120 h of  fermentation using groundnut  cake
extract  as  medium.  Hence,  L-asparaginase  production  was  enhanced  by 1.49 fold by
mutation.  Also,  attempts  were made to enhance the L-asparaginase production of  the
prototype and the mutant strains by whole-cell immobilization in gelatin. The medium
with an initial  pH 8.5 was inoculated with free and immobilized cells  separately and
subjected to fermentation at  40oC at  200 rev/min. In  an immobilized cell  system,  the
enzyme production was enhanced by 1.10 fold compared to the conventional free-cell
fermentation. The immobilized cells retained their ability to produce L-asparaginase over
three cycles and the activity remained between 49.4 IU-18.3 IU (mutant strain) and 33.15
IU-12.9 IU (prototype) throughout the three cycles,  with the highest  activity obtained
during the first cycle. Hence, the gelatin-immobilized cells of  S.gulbargensis  mu24 can
be  explored  as  an  effective  biocatalyst  which  can  be  repeatedly  used  for  maximum
production of L-asparaginase.
• Sreenivasulu et  al[35] (2009) The  purpose  of  the  present  investigation  is  to  enhance
production  of  chemotherapeutically  important  anti  cancer  enzyme  L-asparaginase  by
subjecting  the  indigenous  L-asparaginase  producing  strain  Aspergillus  sp.  VS-26  to
improvement  by  natural  selection  and  random  mutagenesis  [UV  and  ethyl  methyl
sulphonate,  (EMS)  ]  .The  isolation  of  mutants  and  the  enzyme  activity  of  selected
mutants  were  described.  The  best  natural  selectant  VNS-8  showed  2.2%  higher  L-
asparaginase activity than the wild strain (VS-26). The L-asparaginase yield of the best
UV mutant VUV-5 was 31.7% higher than the parent strain (VNS-8) and 34.6% higher
than the wild strain (VS-26).  Also,  the L-asparaginase yield of  the best  EMS mutant
VEM-9 was 38.8 % higher than the parent strain (VUV-5) and 87 % higher than the wild
strain (VS-26). The results were indicated that UV and EMS were effective mutagenic
agents  for  strain  improvement  of  Aspergillus  SP.  VS-26  for  enhanced  antitumor  L-
asparaginase productivity.
IMMOBILIZATION: 
• Deepali BISHT et al [36] Suitability of three matrices  viz.  agarose, sodium alginate and
polyacrylamide for immobilization of mutant cells of  Pseudomonas aeruginosa  MTCC
10,055  was  investigated.  Of  these,  agarose  was  proved  to  be  the  best  exhibiting
maximum enzyme production (4363.4 U/mL) followed by polyacrylamide gel (2172.3
U/mL) whereas,  alginate beads were the poorest. The one-variable-at-a-time approach
suggested agarose, 2.0%; immobilized bead, 4.0 g blocks/50 ml and initial cell loading of
0.8 g in the matrix as optimum conditions for maximum lipase production (5982.3 U/mL)
after 24 h of incubation. However, RSM studies determined the optimum values of these
variables as 1.96%, 4.06 g blocks/50 mL and 0.81 g cells in matrix for maximum lipase
production  (6354.23  U/mL)  within  22.54  h  of  incubation.  The  agarose  blocks  were
reusable  for  seven  cycles  without  any  significant  loss  in  lipase  yield.  Bench-scale
bioreactor  level  optimization  resulted  in  further  enhancement  in  lipase  yield  (6815.3
U/mL)  at  0.6  vvm  aeration  and  100  rpm  agitation  within  only  20  h  of  incubation.
Presumably,  this  is  the  first  attempt  on  lipase  production  by  immobilized  cells  of
P.aeruginosa  at  bioreactor  level.  The  agarose  immobilized  mutant  cells  claimed  its
potential candidature for alkaline lipase production at industrial level.
• Kattimani et al[37] (2009) in the present study, Streptomyces gulbargensis and its mutant
form, S.gulbargensis mu24, immobilized on polyurethane foam were investigated for the
production of L-asparaginase using groundnut cake extract as medium. The medium with
an initial pH of 8.5 was inoculated with free and immobilized cells separately and then
subjected to  fermentation  by incubation at  40oC and shaking at  200 rev/min.  In  the
immobilized  cell  system,  enzyme  production  was  enhanced  by  approximately  30%
compared  to  the  conventional  free  cell  fermentation.  The  immobilized  cells  were
subjected to repeated batch fermentation processes to determine their reusability. These
cells retained their ability to produce L-asparaginase over seven cycles and the activities
remained  between  16.2-41.3  IU/ml  and  39-60  IU/ml  for  S.gulbargensis  and
S.gulbargensis mu24, respectively. The maximum enzyme titer was obtained during the
third  batch  by  both  strains.  However,  the  mutant  strain  was  more  potent  for  L-
asparaginase  production  than  the  prototype.  Therefore,  the  polyurethane  foam
immobilized cells of  S.gulbargensis mu24 can be proposed as an effective biocatalyst,
which can be repeatedly used for maximum production of  L-asparaginase.
PRODUCTION:
• SUNDARAMOORTHI et al [38] (2012) Enzymes are proteins that catalyze (i.e., increase
the rates of) chemical reactions. The manufacture of an enzyme for use as a drug is an
important  facet  of  today’s  pharmaceutical  industry.  Microbial  L-Asparaginase  (L-
Asparaginase  amido  hydrolase)  has  been  widely  used  as  a  therapeutic  agent  in  the
treatment  of  certain  human  cancers,  mainly  in  acute  lymphoblastic  leukemia.
Thermophilic fungi can be grown in minimal media with metabolic rates and growth
yields comparable to those of mesophilic fungi. L-asparaginase perform essential role in
the  treatment  of  acute  lymphoblastic  leukemia,  lymphosarcoma  and  in  many  other
clinical  experiments  relating  to  tumour  therapy  in  combination  with  chemotherapy.
Fungal isolates were isolated from soil samples collected from different regions of the
Arabian Sea, using potato dextrose agar (PDA) medium by serial dilution method. The
inoculated agar  plates  were  incubated at  37˚C for  4  to  7  days.  Twelve isolates  were
selected and the isolated strains were screened by plate assay method using Czapek Dox
medium and potential strains were used for the production of L-Asparaginase.  It  was
found out that among the twelve isolates five showed significant production. One IU of
L-Asparaginase is the amount of enzyme which liberates 1µmol of ammonia per minute
per ml [µmole/ml/min]. From this work we conclude that more than 80% of the fungal
strains from marine soil sample had the ability to produce the enzyme L-Asparaginase.
The highest immobilized activity and highest immobilization yield were obtained with
Silica gel carrier.
• Rashmi  et al [39] (2012) Pseudomonas aeruginosa BGNAS-5 a locally isolated bacteria
was  selected  for  production  of  L-glutamianse  in  minimal  fermentation  broth.  The
optimization of fermentation process reveals that the maximum enzyme activity 46 IU at
pH 7, 48 IU at temperature 360C, 36 IU at 72 hours incubation, 64 IU maltose as carbon
source and 62 IU glutamin as nitrogen source. With this optimized fermentation broth
Pseudomonas aeruginosa BGNAS-5 explored as promising organism for the production
of an enzyme Lglutaminase used as anticancer agent.
• Saleem Basha  et al [40] (2009) the objective of this investigation was to isolate marine
actinomycetes,  screen  them  for  Lasparaginase  activity  and  characterize  the  enzyme.
Marine actinomycetes were isolated from sediment samples  obtained from Tamilnadu
and Kerala in India. The isolates were identified as actinomycetes by microscopical and
biochemical tests. Production of L-asparaginase was carried out in three different media,
namely,  solid-state  media,  Tryptone Glucose Yeast  extract  (TGY) broth and Tryptone
Fructose Yeast extract (TFY) broth.. The enzyme was purified to near homogeneity by
ammonium sulphate precipitation, dialysis, gel filtration on Sephadex G-100 column and
SDS-PAGE. Among 10 marine isolates subjected to preliminary screening, only isolates
S3, S4 and K8 showed potential for L-asparaginase activity. All three marine soil isolates
synthesized asparaginase with yield  ranging from 24.6 to 49.2 IU/ml.  Soil  isolate  S3
showed the highest productivity of 49.2 IU/ml with a protein content of 65 µg/ml and
optimum activity at pH 7.5 and 50 ºC. The apparent Km value for the substrate was 25
µM. Mg2+ ion slightly stimulated activity while Cu2+, Zn2+ and EDTA were inhibitory. The
study revealed that marine actinomycetes may be a potential source of high yield.
• Manikandan et al [41] (2010) Evaluation of fermentation process parameter interactions
for the production of l-asparaginase by Pseudomonas aeruginosa. Box-Behnken design
of experimentation was adopted to optimize nutritional sources, physiological (incubation
period) and microbial (inoculum level).The experimental results and software predicted
enzyme  production  values  were  comparable.  Incubation  period,  inoculum  level  and
nutritional source (soybean) were major influential parameters at their individual level.
Interaction data of the selected fermentation parameters could be classified as least and
most significant at individual and interactive levels. All selected factors showed impact
on                  L-asparaginase enzyme production by this isolated microbial strain either at
the individual or interactive level. Incubation temperature, inoculums concentration, and
nutritional source (soybean) had impact at individual level. Significant improvement in
enzyme production by this microbial isolate was noted under optimized environment.
• HEINEMANN et  al[42] (1969) Production  of  a  tumor-inhibitory  asparaginase  by
submerged  fermentation with  Serratia  marcescens ATCC 60 was  studied to  ascertain
optimal nutritional conditions for large-scale production leading to enzyme purification
studies.  Five  strains  of  S.  marcescens  were  screened in  shake-flask studies  and were
found  to  produce  0.8  to  3.7  IU/ml  48  hr  after  inoculation.  The  requirements  for
asparaginase  production  with  S.  marcescens  ATCC  60,  the  high  producing  strain,
included the following: 4% autolyzed yeast extract medium (initial pH 5.0), an incubation
temperature of 26 0C, and limited aeration for a zero level of dissolved oxygen during the
fermentation.  Addition  of  various  carbohydrates  to  the  fermentation  medium did  not
enhance yields. The peak cell population in the fermentation medium and the maximal
asparaginase yields occurred simultaneously.  Highest  enzyme yields were found when
the  pH  of  the  fermentation  cycle  rose  to  approximately  8.5.  Yields  of  4  IU  of
asparaginase/ml of cell suspension have been obtained consistently in 40 to 42 hr from
10-liter volumes (500 ml/4-liter bottle) produced on a reciprocating shaker. Scale-up to a
60-liter fermentor yielded 3.1 IU/ml in 35 hr.
PURIFICATION:
• Suchita  et  al  [43] (2010) L-asparaginase  was  extracted  from  Erwinia  carotovora  and
purified by ammonium sulfate fractionation (60–70%), Sephadex G-100, CM cellulose,
and  DEAE  Sephadex  chromatography.  The  apparent  Mw  of  enzyme  under  none
denaturing and denaturing conditions was 150 kDa and 37  ± 0.5 kDa, respectively. L-
asparaginase  activity  was  studied  in  presence  of  thiols,  namely,  L-cystine  (Cys),  L-
methionine  (Met),  N-acetyl  cysteine  (NAC),  and  reduced  glutathione  (GSH).  Kinetic
parameters in presence of thiols (10–400 µM) showed an increase in Vmax values (2000,
2223, 2380, 2500, and control 1666.7 µmoles mg−1min−1) and a decrease in Km values
(0.086,  0.076,  0.062,  0.055  and  control  0.098mM)  indicating  nonessential  mode  of
activation. KA values displayed propensity to bind thiols. A decrease in Vmax/Km ratio
in concentration plots showed inverse relationship between free thiol groups (NAC and
GSH) and bound thiol group (Cys and Met). Enzyme activity was enhanced in presence
of thiol  protecting reagents  like  dithiothreitol  (DTT),  2-mercaptoethanol  (2-ME),  and
GSH, but inhibited by p-chloromercurybenzoate (PCMB) and iodoacetamide (IA).
• Balasubramanian  et  al [44] (2012): L-asparaginase  (L-asparagine  amido  hydrolase,
E.C.3.5.1.1) is an extra cellular enzyme that has received considerable attention since it is
used as an anticancer agent. In the present study, the fungal isolates from marine soils
were screened for the L-asparaginase production by using modified Czapek Dox agar
containing L-asparagine and phenol red as indicator. This production of L-asparaginase
was produced through submerged fermentation by using isolates Aspergillus terreus. This
production  of  L-asparaginase  was  achieved  through  optimization  of  fermentation
parameters  and  it  showed  maximum  of  enzyme  activity.  After  the  production  of  L-
asparaginase were used for purification by chromatography techniques. The purified L-
asparaginase was used for the characterization such as HPLC assay of L-asparaginase
activity and Molecular weight determination. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) of the purified enzyme revealed it was one peptide chain of
94 kDa. The amino acid composition of the purified enzyme was also determined.
ASSAY OF L-ASPARAGINASE:
• GAFFAR et  al [46]  (1977) Asparaginase was found in the soluble fraction of  cells  of
Azotobacter vinelandii, and its activity remained the same during growth of the organism
in a nitrogen-free medium. The specific activity and the yield of A. vinelandii Increased
twofold  in  the  presence  of  ammonium sulfate.  Within limits,  the Temperature  (30 to
37°C) and pH (6.5 to 8.0) of the medium showed little effect on the levels of enzyme
activity. The enzyme was purified to near homogeneity by Standard methods of enzyme
purification, including affinity chromatography, and had optimum activity at pH 8.6 and
48°C.  The approximate molecular  weight  was 84,000. The apparent K,  value for  the
substrate  was 1.1 x 10-4 M. Metal  ions or  sulfhydryl  reagents  were not required for
enzyme activity. Cu2+,Zn2+, and Hg2+ showed concentration-dependent inhibition, whereas
amino and keto acids had no effect on the enzyme activity. Asparaginase was stable when
Incubated with rat serum and ascites fluid. The enzyme had no effect on the membrane of
sheep erythrocytes and did not inhibit the incorporation of radioactive precursors into
deoxyribonucleic acid,  ribonucleic  acid,  and protein in Yoshida ascites sarcoma cells.
Asparaginase activity was not detected in the tumor cells.
• Thirunavukkarasu et al[47] (2011) Symptomless endophytic fungi isolated from seven
green algae,  six  brown algae and six red algae occurring along the southern coast  of
Tamilnadu, southern India were screened for the production of  L-asparaginase enzyme.
Of the 82 endophyte isolates, 64 were positive for the enzyme. A Fusarium sp. isolated
from the thallus of Sargassum wightii and a sterile mycelial form isolated from the thallus
of Chaetomorpha sp. showed maximum activity of the enzyme. The mycelia growth of
Fusarium sp. was positively correlated with enzyme production. In a time course study,
maximum enzyme activity was observed on the 5th day of growth of this fungus. The
optimum pH for  enzyme activity  was  pH 6.2.  High  concentration  of  glucose  in  the
medium as C source inhibited enzyme production by the fungus. Endophytes of tropical
seaweeds appear to be a good source of this therapeutic enzyme.
• Borah  et al [48] (2012) Asparaginase s are anti-cancer agent used in the lymphoblastic
leukemia chemotherapy. Asparaginase is hydrolytic enzyme and is produced by a large
number of microorganisms. The production of asparaginase enzyme was carried out by
using L-Asparagine as a substrate with the help of  E. coli,  isolated from sewage. The
enzyme was purified by salt precipitation, dialysis and ion exchange chromatography.
The enzyme activity was found to be 0.039 U/ml/min and the molecular  weight was
determined as 153 KDa with the help of SDS-PAGE. The Optimum temperature and pH
was recorded as 55oC and 6 respectively.  The study has shown the capability of the
enzyme to withstand high temperature and hence can be considered as thermo stable
enzyme. 
• Siddalingeshwara et al [49] (2011) this paper describes production and characterization of
L-asparaginase from  Aspergillus terreus  KLS2. This               L-asparaginase was
produced  through  solid  state  fermentation  by  using  carob  pod  as  a  substrate.  This
production  of  L-asparaginase  was  achieved  through  optimization  of  fermentation
parameters  and  it  showed  6.05  IU  of  enzyme  activity.  After  the  production  of  L-
asparaginase were used for purification by chromatography techniques. The purified L-
asparaginase  was  used  for  the  characterization.  The  general  properties  were used for
characterization of L-asparaginase is effect of pH and temperature, stability of pH and
temperature  on  L-asparaginase.  Even  the  substrate  specificity  was  also  studied.  The
optimum pH 9.0 retains 100% of residual activity and 450C temperature on Lasparaginase
retains 100% residual activity. Stability of pH 8.0 retains 100% activity and temperature
70 0C at 30 and 60 min. L-asparagine was used as a specific and natural substrate to the
L-asparaginase and retain 100% relative activity.
SDS-PAGE:
• Jayaramu et al [51] (2010) L-Asparaginase is an important component in the treatment of
acute  lymphoblastic  leukemia  in  children.  The  manufacture  of  L-asparaginase  by
Emericella  nidulans  were  carried  out  by  novel  flask  method  for  screening.  Using
modified  Czapek  Dox  both  containing  L-asparagine  and  phenol  red  as  indicator.  L-
asparaginase  productions  were  detected  by change  into  pink  colour  in  flask.  Further
confirmations of L-asparaginase synthesis were carried out by thin layer chromatograph.
Production of L-asparaginase was carried out by using pH, temperature and inoculums
sizes for optimization process. The pH 6, temperature 30  0C and 0.75 ml of inoculums
were used.
• Saravanan et al [52] (2011) L-asparaginase is an important chemotherapeutic agent used
for the treatment of  a  variety of lymphoproliferative disorders,  lymphomas and acute
lymphoblastic leukemia. In recent years, the use of              L-asparaginase in the
treatment of leukemia and other lymphoproliferative disorders has expanded immensely.
In view of the potential applications of L-asparaginase and the need for development of
economical methods for improved enzyme production with an overall aim of reducing the
cost of the industrial process, solid state fermentation (SSF) can serve as an excellent
alternative  for  increasing  enzyme  yields.  Hence  present  investigation  was  aimed  at
exploring  the  synthetic  ability  of  Lasparaginase  from  Pectobacterium  carotovorum
(MTCC  1428)  and  Bacillus  circulans  (MTCC  490)  by  providing  suitable  synthetic
mediums.
OTHER SUPPORTIVE LITERATURE:
• Hegazy et al [53] (2012) this work aimed to characterize recombinant strains, with a high
production level  of  L-asparaginase,  previously obtained by protoplast  fusion between
Bacillus subtilis and Bacillus cereus. The genetic relationship between fusants and their
parents was determined using a simple PCR restriction fragment length polymorphism
(RFLP) of 16S rDNAs -based method, and by analyzing the specifi  c L-asparaginase
genes  and  protein  patterns.  Our  results  indicate  that  all  fusants  have  morphological
characteristics  and specific  L-asparaginase genes  similar  to  the  Bacillus  cereus strain
whereas protein pattern and 16S rDNAs -RFLP analysis show mixed characteristics from
both  parents.  Different  genetic  relationships  were  found  between  each  fusant  and  its
parental strain. These results confirm that protoplast fusion is an important technique in
strain improvement. It was used to combine genes from different organisms for creating
strains with desired properties.
• Kavitha  et  al [54]  (2012) an  enzyme-based  drug,  L-asparaginase,  was  produced  by
Nocardia  Levis  MK-VL 113  isolated  from  laterite  soils  of  Guntur  region.  Cultural
parameters  affecting  the  production  of  L-asparaginase  by  the  strain  were  optimized.
Maximal  yields  of  L-asparaginase  were  recorded  from  3-day-old  culture  grown  in
modified  asparagine-glycerol  salts  broth  with  initial  pH  7.0  at  temperature  30 0C.
Glycerol (2%) and yeast extract (1.5%) served as good carbon and nitrogen sources for
L-asparaginase  production,  respectively.  Cell-disrupting  agents  like  EDTA  slightly
enhanced the productivity of L-asparaginase. Ours is the first paper on the production of
L-asparaginase by N. Levis.
• Jha  et  al  [55] (2012) L-Asparaginase  (E.C.  3.5.1.1.),  also  known  as  L-asparagine
amidohydrolase  is  the  enzyme  with  anti-tumor  activity  and  is  well  accepted  as  a
chemotherapeutic agent against the acute lymphoblastic leukemia and lymphosarcoma.
This  article  has  briefly  touched  nearly  all  the  industrial  and  clinical  aspects  of  L-
Asparaginase and provides the recent update of the topic. The article includes a brief
introduction to the topics, mechanism of action, a little information about the structure,
sources  of  enzyme,  purification,  optimum  conditions  for  the  enzyme  production,
recombinant strains for higher productivity and formulation of the enzyme.
SCOPE OF WORK
                   Since the observation Ashraf A. El-Bessoumy et al that L-asparaginase from
Pseudomonas  aeruginosa has  antitumor  activity  similar  to  that  of  guinea  pig  serum  which
discovered by Kidd (1953) few numbers of papers have been published on the production of L-
asparaginase  by  Pseudomonas  aeruginosa.  Thus,  a  large  amount  of  L-asparaginase  to  be
supplied to cure so many patients around the world whose are suffering from different types of
cancers such as leukemia and other malignant neoplasms in human. However the administration
of L-asparaginase for  a long time cause production of  antibodies  which causes  anaphylactic
shock or neutralization to the cancer patient, therefore, new                          L-asparaginase with
different immunological effect to be discover to avoid the anaphylactic shock. To produce such
enzyme requires some changes in parameters, strain and optimization of the medium.
OBJECTIVE OF WORK
There  are  some  researches  has  been  done  on  biosynthesis   L-Asparaginase  using
Pseudomonas  aeruginosa  as  a  source.  The  fermentations  were  carried  out  by  solid  state
fermentation technique but there are some researches had proved that submerged fermentation
technique is better than solid state fermentation technique for bacteria and fungi because they
require moisture for their growth. 
The  present  research  work  focus  to  increase  the  production  of  L-asparaginase  By
modifying the fermentation techniques.  The following steps  were carried out to improve the
productivity of L-asparaginase:  
     
         1. Irradiation 
         2. Immobilization of the whole-cell Pseudomonas aeruginosa 
         3. Optimize the fermentation medium (Soybean Casein Digest
             Medium) by adding phosphate buffer 
         4. Submerged fermentation technique will be use for the production 
         5. Confirmation of the product will be carried out by SDS-PAGE 
PLAN OF WORK
      1. Collection of the strain culture
      2. Screening the Culture for L-Asparaginase by Rapid plate method.
      3. Irradiation
      4. Immobilization of Whole-Cell
      5. Fermentation (Submerged Fermentation)  
      6. Assay of L-asparaginase from crude extract
      7. Isolation
      8. Purification 
      9. Characterization of L-asparaginase  
            Effect of pH on enzyme activity
            Effect of temperature on enzyme activity
       10. Conformation of enzyme production by SDS-PAGE
MATERIALS AND METHODS
LIST OF CHEMICALS USED:
    Table: 4
Sl No                    Chemical        Company
      1 Soyabean meal broth                 Himedia 
      2 Nutrient broth       Himedia 
      3 Nutrient agar  Himedia 
      4 L-asparagine  Himedia
      5 Grams iodine Otto kemi
      6  Malachite green Nice chemical     
      7  Methylene blue Otto kemi
      8 Safranin Nice chemical     
      9 Nesseler’s reagent Reachem
     10 Immersion oil Qualigens 
     11  Ferrous sulphate Nice chemicals
     12 Zinc sulphate Qualigens 
     13 Magnesium sulphaate  Micro fine chemicals
     14 Cupper nitrate Merck 
     15 Potassium chloride Merck
     16 Potassium dihydrogen phosphate Himedia 
     17 Sodium chloride  Merck
     18 Sodium hydroxide Finar 
     19  Sodium alginate Otto kemi
     20 Magnesium chloride Qualigens 
     21 D-glucose Qualigens
     22 D-fructose Qualigens
    23 Sucrose 
    24 Agar-agar SRL
    25 Phenol red dye Reachem
    26 Sulphuric acid Finar
    27 Hydrochloric acid Finar
    28 Trichloro acetic acid SRL
    29 Absolute alcohol Jiangsu huaxi       international
    30 Ammonium per sulphate SRL
    31  Bromo thymol blue Merck
    32 TE buffer Medox
SI no                     Chemical        Company
    34  Phosphate buffer
    35 Ammonium sulphate Qualigens
    36  Acrylamide SD fine
    37 Bis acrylamide Qualigens
    38   Petroleum jelly Himedia
    39  Casein Himedia 
       LIST OF INSTRUMENTS USED:
       Table: 5
SI no         Instrument         Manufacturer          Brand
    1 Electronic balance Shimadzu
AY 220
Max-220 g,min-10mg
    2 Electronic balance Shimadzu
 AUX 220
Max-220 g,min-10mg 
Unibloc
    3 Hot air oven    Ashok united  scientific 
company
    4 Colorimeter Aimil Ltd
    5 Water bath Industrial and laboratory tools 
corporation
    6 Centrifuge Remi R8C
    7 Centrifuge Remi RM12C
    8 Centrifuge Remi  R24
    9 Shaker Scigenics Orbitek
Sl no         Instrument         Manufacturer          Brand
  10 Incubator Industrial and laboratory 
tools corporation
S.L-SZ-08
  11 Horizontal laminar        
airflow cabinate
Air tech
  12 Vertical SDS-PAGE 
electrophoresis
 Medox
  13 Gel documentation 
system
Vilber lourmat V03-7833
  14 Autoclave Medica instrument Mfg Equitron
  15 Microwave  oven Whirl pool   
  16 Glass ware Qualigens
  17 Motor stirrer Kadavil electro mechanical 
industries
  18 Rocker Scigenics Orbitek
  19 Microscope Micron optik Bino cxi
  20 Vortex Spinix
  21 Refrigerator Sub Zero lab instruments
METHODOLOGY
1. COLLECTION OF THE STRAIN CULTURE:
The Bacterial strain of Pseudomonas aeruginosa was collected from MTCC Chandigarh.
2. SCREENING THE CULTURE FOR L-ASPARAGINASE BY RAPID       PLATE 
METHOD [27]:
The strain was screened for L-asparaginase production using a method in which modified
M9 medium (composition for 1 l: 6.0 g Na2HPO4·2H2O; 3.0 g KH2PO4; 0.5 g NaCl2; 5.0 g L-
asparagine; 1mole/litre of 2.0 ml MgSO4.7H2O; 0.1mole/litre of 1.0ml CaCl2.2H2O; 10 ml of
2.0% w/v glucose;  and 20.0 g agar) incorporated with a pH indicator (phenol red) was used
(Gulati  et al., 1997). L-asparaginase activity was identified by formation of pink zone around
colonies.
Media: Modified M9 Media
Composition of the Modified Media [28]:
Table: 6
                Chemicals             Amount for 1000ml
Disodium hydrogen phosphate.2H2O                   6.0g
Potassium di hydrogen phosphate.                   3.0g
Sodium chloride                   0.5g
L-asparagine                   5.0g
Magnesium sulphate(1mole/litre)                   2.0ml
Calcium chloride(0.1mole/litre)                  1.0ml
20% glucose  stock solution                  10.0ml
Agar                  20.0g
Distilled water                 1000ml
Media pH -7.0
Preparation of various concentration of dye [29]:
1- 2.5% stock solution of phenol red dye was prepared in ethanol and the pH was         adjusted 
to 7.0 using 1mole/litre of sodium hydroxide.
2- The stock solution of the dye, ranging from 0.04ml to 0.3ml, was added to 1000ml of 
modified M9 medium, given final dye concentrations of 0.001% to 0.009% respectively.
Procedure [30-33]:
1-20ml of 0.005% of the above dye containing media was poured into a Petri plates.
2- Two control plates were also prepared by using modified M9 medium .Among them one was 
without dye and the other one was without asparagine (instead containing NaNO3 as nitrogen 
source).
3- The strain was inoculated in Petri plates.
4- The plates were incubated for 18hrs at 37oC.
5- The zone diameter where measured after 18hrs of incubation
3. IRRADIATION OF THE STRAIN [34-35]:
The strain has been mutated by Physical method (UV irradiation), the mutation of the
strain was done by exposing the strain to UV irradiation from different distances for different
times as in the following column.
Table: 7
S,N
O
DISTANCE FROM THE 
UV LAMP
              In  5cm
DISTANCE FROM THE UV
LAMP
                In  10cm
DISTANCE FROMTHE 
UV LAMP
                  In  15cm
           TIME OF 
EXPOSURE
       TIME OF EXPOSURE       TIME OF EXPOSURE
1    10    20    40     10     20   40    10     20    40
2    10    20    40     10     20   40    10     20    40
3    10    20    40     10     20   40    10     20    40
4    10    20    40     10     20   40    10     20    40
5    10    20    40     10     20   40    10     20    40
6    10    20    40     10     20   40    10     20    40
7    10    20    40     10     20   40    10     20    40
8    10    20    40     10     20   40    10     20    40
9    10    20    40     10     20   40    10     20    40
4.  IMMOBILIZATION OF WHOLE CELL [36-37]:
The  culture  strain  has  been  immobilized  by  gel  entrapment  technique  using  sodium
alginate as supporting material. The growing bacterial cells were harvested from culture broth by
centrifugation at 12000×g for 10 min. The supernatant was removed and the pellet (0.2g) was
washed twice with sterile distilled water and mixed with sterilized 20 mL of 4 %( w/v) sodium
alginate  prepared  in  distilled  water.  The  slurry was  extruded  through  a  syringe  into  0.2  M
calcium chloride  solution  with  constant  stirring.  The  beads  were  allowed to  cure  in  0.2  M
calcium chloride solution for 24 h at 4 °C followed by washing with sterile distilled water for 3
to 4 times and preserved in Tris-HCl buffer (pH-8.0) at 4 °C until use.
5. FERMENTATION (SUBMERGED FERMENTATION) [38-39]:
Submerged fermentation was carried out by modified minimal fermentation broth that
contained an amount of Soybean Casein Digest Medium broth. Comprising of Pancreatic digest
of  casein  1.7gm,  Papaic  digest  of  soyabean  meal  0.3gm,  Sodium chloride  0.5gm,  Dextrose
0.25gm, dibasic potassium phosphate 0. 25gm in 100ml of water and Final pH ( at 25°C) 7.3±0.2
then contained in a 250 ml Erlenmeyer flask, was inoculated separately with the mutants and
wild strain of  Pseudomonas aeruginosa and incubated at 37 ºC in a shaker at 200 rev/min for 3-
6 days. At the end of the fermentation period, the crude enzyme was prepared by centrifugation
at 10000 rpm for 20 min. The cell-free supernatant was taken as the crude enzyme.
6. ASSAY OF L-ASPARAGINASE FROM CRUDE EXTRACTS [40-42]:
Assay of enzyme was carried out as per Imad et al, 0.5 ml of 0.04 M asparagine was
taken in a test tube, to which 0.5 ml of 0.5 M buffer (acetate buffer pH 5.4), 0.5 ml of enzyme
and 0.5 ml of distilled water was added to make up the volume up to 2.0 ml and incubate the
reaction mixture for 30 min. After the incubation period the reaction was stopped by adding 0.5
ml of 1.5 M TCA (Trichloroacetic acid). 0.1 ml was taken from the above reaction mixture and
added to 3.7 ml distilled water and to that 0.2 ml Nessler’s reagent was added and incubated for
15  to  20  min.  The  OD  was  measured  at  450  nm.  The  blank  was  run  by  adding  enzyme
preparation after the addition of TCA. The enzyme activity was expressed in International unit.
International Unit (IU) 
One IU of L-asparaginase is the amount of enzyme which liberates 1 µmol of ammonia per 
minute per ml [µmole/ml/min].
                        
                           Units/mL enzyme =   (µmole of NH3 liberated) (2.5) ×100
            (0.1) (30) (1)
                                                     
2.5 = Initial volume of enzyme mixture (mL)
0.1 = Volume of enzyme mixture used in final reaction (mL)
30 = Incubation time (minutes)
1 = Volume of enzyme used (mL)
7.   ISOLATION [18]:
The extracellular crude enzyme was prepared at the end of the fermentation period by the
addition of 90 ml of a 0.01 M phosphate buffer pH 7 to the fermented medium, shaking for 15
min followed by centrifugation at 8,000 rpm for 20 min. The cell free supernatant was used as
the crude enzyme preparation.
8. Purification [43-44]:
The purification was carried out at 4ºC on the crude extract, according to the modified
method of Distasio et al. (1976).
Ammonium sulfate  fractionation:  Finely  powdered  ammonium sulfate  was  added  to  80%
saturation. The mixture was left for 12 hrs at 4oC, followed by centrifugation at 8,000 rpm for 20
min at 4oC.The precipitate was dissolved in a 0.01 M phosphate buffer pH 8.5 and dialyzed
overnight against the same buffer      at 4oC.
9. ESTIMATION OF L-ASPARAGINASE BY LOWERY METHOD [45]:
This procedure is sensitive because it employs two colour forming reactions. It uses the
Biuret reactions in which Cu2+ in presence of a base reacts with a peptide bond  of protein under
alkaline conditions resulting in reduction of  cupric  ions  (Cu2+) to cuprous ions  (Cu+),  and
Lowry’s  reaction  in  which  the  Folin  Ciocalteau  reagent  which  contains  phosphomolybdic
complex which is a mixture of sodium tungstate, sodium molybdate and phosphate,  along with
copper sulphate solution and the protein, a blue purple colour is produced which can be assessed
by measuring the absorbance at 650 nm
Materials Required:
1)    Standard Protein solution [1mg/ml].
2)    Alkaline copper reagent.
3)    Folin’s Ciocalteau reagent.
4)    Colorimeter
5)    Pipettes.
 PROCEDURE: 
Arrange the reagent solutions prepared, on the table.
Label the test tubes with the volume taken and arrange them in a test tube rack.
Pipette out the standard protein solution from the standard flask into the test tubes labelled 
[0.2ml-1ml].
Pipette a known volume of the   unknown solution to the tube labelled “unknown” arranged in 
the test tube rack.
To the test tube labelled ‘Blank’, add 1ml of distilled water using a micropipette.
Volume in each test tube is made up to 1 ml by adding distilled water.
 Add 5ml of alkaline copper reagent to all the test tubes.  Vortex and Incubate for 10 minutes at 
room temperature.
The solution in all the test tubes has turned blue in colour.
 After incubation, add 600ul of Folin’s Ciocalteau reagent to all test tubes using micropipette. 
Vortex and Incubate for 20 minutes at room temperature.
After incubation, the color intensity varies accordingly with the concentration of protein present 
in the tubes.
Now record the absorbance of each solution at 650 nm using a colorimeter.
Plot the absorbance against amount of protein in milligrams to get a standard    calibration 
curve.  Check the absorbance of unknown sample and determine the   concentration of the 
unknown sample from the standard curve plotted.
10. CHARACTERIZATION OF L-ASPARAGINASE [46-49]:
 After fermentation process L-asparaginase were separated out by using filtration, 
centrifugation, and ammonium sulfate salt precipitation , this partially purified enzyme were 
used for characterization studies.
Effect of temperature on enzyme activity:
The  enzyme  was  assayed  in  the  reaction  mixture  containing  2.0ml  of  0.5%  casein
solution in 0.1M carbonate buffer (pH 9.3) and 0.1ml of enzyme solution in the total volume of
2.1 ml. After incubation at 5oC, 37oC, 55oC and 80oC for 5mins, the reaction was stopped by
adding 3.0 ml of 10% ice cold TCA and centrifuged at 10,000 rpm for 5 min. The reading was
taken at 660 nm in UV- Spectrophotometer to monitor the enzyme activity.
Effect of pH on enzyme activity:
The above method was repeated using 0.1M carbonate buffer of different pH (2, 4, 6, 8 
and10) and the enzyme activity was monitored spectrophotometrically.
11.  CONFIRMATION OF ENZYME PRODUCTION BY SDS-PAGE [50-52]:
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was carried out
in a 3-mm slab gel of 6% acrylamide in a Tris-borate buffer pH 7.1 containing 0.1% SDS. The
gels were stained with 0.025 Coomassie brilliant blue R-250 and destained.
Protocol
1. Prepare polyacrylamide gel according to standard protocol.
2. Load samples and run gel at 50 mA (2 gels run in 1x SDS Running Buffer.
3. At this point, the gel stained with Coomassie blue (see below).
4. Place gel in a plastic container. Cover with isopropanol fixing solution and shake at room 
temperature. For 0.75 mm-thick gels shake 10 to 15 min; for 1.5 mmthick gels, shake 30 
to 60 min.
5. Pour off fixing solution. Cover with Coomassie blue staining solution and shake at RT for
2 hr.
6. Pour off staining solution. Wash gel with 10% acetic acid to destain, shaking at RT.
Almost all analytical electrophoresis of proteins were carried out under conditions that
ensure dissociation of the proteins into their peptide subunits that minimize aggregation. The
purified enzyme was resolved in SDS-PAGE by discontinuous buffer systems.  The molecular
weight of purified product of               L-asparaginase was determined by 10% SDS-PAGE (3.2
ml of 30%Acrylamide, 2.08 ml of 1.5 M Tris (pH 8.8), 0.8 ml of 10% SDS, and 0.08 ml of 10%
Ammonium per sulphate, 0.003 ml of TEMED and 2.56 ml of water). Later the gel was taken out
carefully  and  stained  with  Coomassive  brilliant  blue  until the  bands  were  visible  clearly
identified by Staining and De-staining method.
RESULTS AND DISCUSSIONS
1. SCREENING THE CULTURE FOR L-ASPARAGINASE BY RAPID PLATE METHOD:
   
             Phenol red =0.001%                                           Phenol red =0.003%                                  
      
       Phenol red =0.005%                                       Phenol red =0.007%                                            
                                          
                                          Phenol red =0.009%                                      
                                                     Plates: 1
Phenol red dye concentration range from 0.001% to 0.009%
Zone diameter of screened strain:
Table: 8
SI no
     Phenol red dye     
     Concentration
Zone diameter of 
screened strain
   1           0.001%        30mm
   2           0.003%        29mm
   3           0.005%        28mm
   4           0.007%        26mm
   5           0.009%        22mm
The rapid plate assay using phenol red dye revealed that presence of dye in medium did
not inhibit the growth of the microorganism, Pink colored zone formed around the colony and
size of the colony indicating that the strain capable of producing L-asparaginase .the method was
quick and enzyme production can be observe from the plates as per Gulati et al method (1997).
2. IRRADIATION OF THE STRAIN BY UV IRRADIATION:
     
                Distance=5cm                                              Distance=5cm
                Time      =10min                                          Time      =20min
     
             Distance=5cm                                             Distance=10cm
             Time      =40min                                           Time      =10min                   
      
            Distance=10cm                                                Distance=10cm
             Time      =20min                                                Time      =40min
            
               Distance=15cm                                              Distance=15cm
               Time      =10min                                              Time      =20min
                  
                  Distance = 15cm                              
                  Time      = 40min                                
                     Plates: 2
Distance = the plate distance from UV lamp                                                           Time       = time
of exposure to UV irradiation
The strain of Pseudomonas aeruginosa was exposed to UV irradiation from Philips lamp
to  improve  the  productivity  of  the  strain  from different  distance  (5,  10  and  15cm)  and  for
different time (10, 20 and 40minutes) as per Amena et al (2012). 
3. IMMOBILIZATION OF THE WHOLE-CELLS:
      
                           ir1                                                     ir2
       
                          ir3                                                               ir4
        
                          ir5                                                           ir6
        
                        ir7                                                            ir8
         
                          ir9                                                        wild strain
     
Plates: 3
The whole cells of the mutated and the wild strains of Pseudomonas aeruginosa were
immobilized by entrapment immobilization using sodium alginate as supporting material after
cells were entrapped in the gel they left in the calcium chloride solution in the cool condition to
cure then beads were removed from the solution and ready for use as per Deepali bisht et al.
4. ASSAY OF L-ASPARAGINASE FROM CRUDE EXTRACTS:
Table: 9
SI no Strain
                                ENZYME ACTIVITY
                                           IU\ml
          Day 3             Day 4          Day 5
    1 Wild               10.83              31.66           16.66
    2  ir1             32.5              21.66           18.33
    3  ir2             21.66              25           22.5
    4  ir3             29.16              32.5           31.66
    5  ir4             29.16              36.66           37.5
    6  ir5             42.5              49.16           43.33
    7  ir6             38.33              45.83           41.66
    8  ir7             30.83              29.16           29.16
    9  ir8             26.66              33.33           22.5
   10  ir9             27.5              28.33           25
    
 C       = wild strain 
ir 1-9 = Irradiated strain
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The assay of crude enzyme at 96 hours (4days) of fermentation showed that mu5 has the
highest yield 49.16 IU\ml of L-asparaginase compare to wild strain which       yield 31.66 IU\ml
of L-asparaginase. Hence the present study clearly indicates that L-asparaginase production was
enhanced by 1.55 fold by mutation and immobilization.
5. ESTIMATION OF L-ASPARAGINASE BY LOWERY METHOD:
 SI no
   
                Sample Absorbance(OD)at 650nm
   1 Test                 0.4
   2 Standard 1                 0.55
   3 Standard 2                 0.93
   4 Standard 3                 1.31
   5 Standard 4                 1.65
   6 Standard 5                 1.78
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L-asparaginase has been estimated by lowery method to determine the concentration of
L-asparaginase in product  by  Pseudomonas aeruginosa.  The concentration of L-asparaginase
was found to be 750µg/ml.
6. CHARACTERIZATION OF L-ASPARAGINASE:
 a) Effect of temperature on enzyme activity:
 Table: 10
SI no Temperature in 0C Enzyme activity
   1             5 0C              29.16
   2            370C              115
   3            550C              40.83
   4            800C              24.16
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Chart: 4     
A temperature profile of L-asparaginase showed that the enzyme had maximum activity at
370C Similar results were recorded for L-  asparaginase from  Pseudomonas stutzeri  MB- 405
(Manna  et  al.,  1995),  E.  carotovora  (Maladkar  et  al.,  1993),  and  Staphylococcus  (Sobis  &
Mikucki, 1991). Also, Qian et al., (1996)
b) Effect of pH on enzyme activity:
         Table: 11
SI no              pH        Enzyme activity
   1                3              20.83
   2                5              70
   3                7              183.33
   4                9              227.5
    5              11              154.16
    6              13               110
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The maximum L-asparaginase activity occurred when it was incubated with an optimum
substrate concentration at pH 9. A similar pH value was obtained for       E.  coli (Castaman &
Rodeghiero, 1993 and Liboshi et al., 1999)
7. CONFIRMATION OF ENZYME PRODUCTION BY SDS-PAGE:
 Molecular characterization of L-asparaginase:
                                                 Figure: 2
Lane 1: Crude extracts (P.aeruginosa).
Lane 2: Ammonium sulphate precipitation.
Lane 3: Phosphate buffer treated.
Lane 4: Molecular Markers.
The partial purification of the L-asparaginase crude extract was loaded on 12% SDS-
PAGE.the  gel  was  stained  with  0.025  Coomassive  brilliant  blue  R-25  and  destained.  The
following standard proteins were used for the molecular weight determination under identical
condition  .M  wt of  standard  markers  Phosphorylase  94  KDa,  BSA  66.5  KDa,  Carbonic
anhydrase 30 KDa, α-lactalbumin 14.4KDa.
 SDS-PAGE showed that the enzyme is  one band by that was apparent molecular weight of
Pseudomonas aeruginosa L-asparaginase was 160 KDa.
SUMMARY AND CONCLUSION
The discovery of the fact that L-Asparaginase is responsible for the action of the guinea-
pig serum against the acute lymphoblastic leukemia has set a milestone in the field of medicine.
After this discovery detailed information about the enzyme has been dug out. It has been proved
that L-Asparaginase from Escherichia coli  and  Erwinia carotovora  has anti-neoplastic activity
against cancer and is being used as anti-cancer drug.
Microbial L-Asparaginase has been widely used as a therapeutic agent in the treatment of
certain  human  cancers.  With  the  development  of  its  new  functions  a  great  demand  for  L-
asparaginase is expected in the coming years [37].
The Bacterial strain of Pseudomonas aeruginosa was collected from MTCC Chandigarh.
The strain was screened for L-asparaginase production using (Gulati et al., 1997) method
in which modified M9 medium was used. At 0.005% the higher productivity of L-asparaginase
was shown by the formation of the biggest pink zone around colonies.
The strain has been irradiated by Physical method (UV irradiation), the irradiation of the
strain was done by exposing the strain to UV irradiation of Philips lamp from different distances
(5, 10 and 15cm) for different times (10, 20 and 40minutes) to get irradiated strain (ir1- ir9).
The  culture  strain  has  been  immobilized  by  gel  entrapment  technique  using  sodium
alginate as supporting material and preserved in Tris-HCl buffer (pH-8.0) at 4 °C until use.
Submerged fermentation was carried out by modified minimal fermentation broth that
contained an amount of  Soybean Casein Digest  Medium broth.  Then contained in a  250 ml
Erlenmeyer flask was inoculated separately with the mutants of  Pseudomonas aeruginosa and
incubated at 37 ºC in a shaker at 200 rev/min for 3-6days. At the end of the fermentation period,
the  crude  enzyme  was  prepared  by  centrifugation  at  10000  rpm  for  20  min.  The  cell-free
supernatant was taken as the crude enzyme.
 Assay of enzyme was carried out as per Imad et  al  (1973) the enzyme  activity was
shown that at the highest productivity of L-asparaginase which              49.16 IU\ml was
achieved by  ir5 compare with 31.66 IU\ml achieved by wild strain. Hence the present study
clearly indicates that L-asparaginase production was enhanced by 1.55 fold by mutation.   
The L-asparaginase was isolated from fermentation media as per El-Bessoumy et al the cell free
supernatant was used as the crude enzyme preparation.
The purification was carried out at 4ºC on the crude extract. according to the modified
method  of  Distasio  et  al.  (1976)  finely  powdered  ammonium  sulfate  was  added  to  80%
saturation. The mixture was left for 12 h at 4oC, followed by centrifugation at 8,000 rpm for 20
min at 4oC. The precipitate was dissolved in a 0.01 M phosphate buffer pH 8.5.
L-asparaginase has been estimated by lowery method to determine the concentration of
L-asparaginase in product  by  Pseudomonas aeruginosa.  The concentration of L-asparaginase
was found to be 1500µg/ml.
Studies  of  enzyme characterization by temperature and pH effect  on enzyme activity
showed that  the  highest  enzyme activity 115  IU\ml  was  shown at  370C of temperature and
enzyme activity of 227.5 IU was shown at pH 9.0.
The  final  product  was  examined  for  molecular  weight  using  SDS-PAGE.  the  result
showed that the M wt of L-asparaginase was 160 kDa when compared with standard molecular
weight protein marker. To conclude that this study showed  by mutation of the strain by UV
irradiation, Immobilization of the whole cell and optimization of the basic fermentation media
the production of L-asparaginase from Pseudomonas aeruginosa was increased up to 1.55 folds
that gives hope to increase the productivity of L-asparaginase which will meet the demand of
patients around the world. 
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